Literature DB >> 1940062

The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome.

J Slowińska-Srzednicka1, S Zgliczyński, M Wierzbicki, M Srzednicki, U Stopińska-Gluszak, W Zgliczyński, P Soszyński, E Chotkowska, M Bednarska, Z Sadowski.   

Abstract

In order to establish the role of insulin in the pathogenesis of lipid abnormalities in hyperandrogenic women with the polycystic ovary syndrome (PCO) 49 women aged 18 to 35 yr with a normal glucose tolerance test were studied. They were divided into two groups: 27 women with PCO (9 obese and 18 nonobese), and 22 healthy women (12 with simple obesity and 10 with normal body weight). In the PCO group, the fasting insulin levels and the insulin response to oral glucose load were higher than in the matched controls. Significantly lower levels of HDL2-cholesterol and higher levels of apolipoprotein B were observed in obese and non nonobese PCO patients. In obese women with PCO this was associated with lower levels of HDL-cholesterol and apolipoprotein A-I (Apo A-I), whereas the levels of total triglycerides and VLDL-triglycerides (VLDL-TG) were increased. Multiple regression analysis in PCO women, after adjustment for age, body mass index and the levels of insulin and sex hormones, showed a strong positive correlation between the fasting insulin levels and total triglycerides and VLDL-TG, while a negative correlation was found between fasting insulin levels and apo A-I. These results indicate that hyperinsulinemia may play a role in the development of lipid disturbances in women with the PCO.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1940062     DOI: 10.1007/BF03346870

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  28 in total

Review 1.  Polycystic ovary syndrome: a changing perspective.

Authors:  S Franks
Journal:  Clin Endocrinol (Oxf)       Date:  1989-07       Impact factor: 3.478

2.  Decreased plasma dehydroepiandrosterone sulfate and dihydrotestosterone concentrations in young men after myocardial infarction.

Authors:  J Słowínska-Srzednicka; S Zgliczyński; M Ciświcka-Sznajderman; M Srzednicki; P Soszyński; M Biernacka; M Woroszyłska; W Ruzyłło; Z Sadowski
Journal:  Atherosclerosis       Date:  1989-10       Impact factor: 5.162

3.  Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome.

Authors:  R A Wild; P C Painter; P B Coulson; K B Carruth; G B Ranney
Journal:  J Clin Endocrinol Metab       Date:  1985-11       Impact factor: 5.958

4.  High blood pressure and hyperinsulinaemia in acromegaly and in obesity.

Authors:  J Słowińska-Srzednicka; S Zgliczyński; P Soszyński; W Zgliczyński; W Jeske
Journal:  Clin Exp Hypertens A       Date:  1989

5.  A role for insulin in the aetiology and course of hypertension?

Authors:  G M Reaven; B B Hoffman
Journal:  Lancet       Date:  1987-08-22       Impact factor: 79.321

6.  Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure.

Authors:  L I Gidez; G J Miller; M Burstein; S Slagle; H A Eder
Journal:  J Lipid Res       Date:  1982-11       Impact factor: 5.922

7.  Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics, and plasma triglyceride levels in normotriglyceridemic man.

Authors:  T A Tobey; M Greenfield; F Kraemer; G M Reaven
Journal:  Metabolism       Date:  1981-02       Impact factor: 8.694

8.  Insulin resistance in nonobese patients with polycystic ovarian disease.

Authors:  R J Chang; R M Nakamura; H L Judd; S A Kaplan
Journal:  J Clin Endocrinol Metab       Date:  1983-08       Impact factor: 5.958

9.  Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations.

Authors:  T A Welborn; K Wearne
Journal:  Diabetes Care       Date:  1979 Mar-Apr       Impact factor: 19.112

10.  Serum lipids and apolipoprotein levels in women with acute myocardial infarction.

Authors:  S Johansson; G Bondjers; G Fager; H Wedel; A Tsipogianni; S O Olofsson; A Vedin; O Wiklund; C Wilhelmsson
Journal:  Arteriosclerosis       Date:  1988 Nov-Dec
View more
  7 in total

Review 1.  Insulin resistance and polycystic ovary syndrome.

Authors:  David A Ehrmann
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

Review 2.  How actual is the dietary treatment in overweighting patients with polycystic ovary syndrome?

Authors:  C Cortet-Rudelli; D Dewailly
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

Review 3.  Polycystic ovarian syndrome: diagnosis and management.

Authors:  Michael T Sheehan
Journal:  Clin Med Res       Date:  2004-02

4.  Cardiovascular risk in women with polycystic ovarian syndrome (PCOS).

Authors:  A S T Bickerton; N Clark; D Meeking; K M Shaw; M Crook; P Lumb; C Turner; M H Cummings
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

Review 5.  Polycystic Ovary Syndrome: Important Underrecognised Cardiometabolic Risk Factor in Reproductive-Age Women.

Authors:  Dinka Pavicic Baldani; Lana Skrgatic; Roya Ougouag
Journal:  Int J Endocrinol       Date:  2015-06-01       Impact factor: 3.257

6.  Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries.

Authors:  Mark J Prodoehl; Nicholas Hatzirodos; Helen F Irving-Rodgers; Zhen Z Zhao; Jodie N Painter; Theresa E Hickey; Mark A Gibson; William E Rainey; Bruce R Carr; Helen D Mason; Robert J Norman; Grant W Montgomery; Raymond J Rodgers
Journal:  Mol Hum Reprod       Date:  2009-08-19       Impact factor: 4.025

7.  Oxidative stress and anti-oxidant defense system in Iranian women with polycystic ovary syndrome.

Authors:  Mahtab Moti; Leila Amini; Soheila Sadat Mirhoseini Ardakani; Sara Kamalzadeh; Masoomeh Masoomikarimi; Moslem Jafarisani
Journal:  Iran J Reprod Med       Date:  2015-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.